Pain Relief for Acute Urolithiasis: The Case for Non-Steroidal Anti-Inflammatory Drugs Peter L. SteinbergSteven L. Chang Current Opinion 10 June 2016 Pages: 993 - 997
Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future Directions Adeeb BulkhiFarnaz TabatabaianThomas B. Casale Leading Article 11 June 2016 Pages: 999 - 1013
Fimasartan: A New Angiotensin Receptor Blocker Hae-Young LeeByung-Hee Oh Review Article 07 June 2016 Pages: 1015 - 1022
Secukinumab: A Review in Ankylosing Spondylitis Hannah A. BlairSohita Dhillon Adis Drug Evaluation 02 June 2016 Pages: 1023 - 1030
Rotigotine Transdermal Patch: A Review in Restless Legs Syndrome Karly P. Garnock-Jones Adis Drug Evaluation 20 June 2016 Pages: 1031 - 1040
Sugammadex: A Review of Neuromuscular Blockade Reversal Gillian M. Keating Adis Drug Evaluation 21 June 2016 Pages: 1041 - 1052
Pimavanserin: First Global Approval Anthony Markham AdisInsight Report 04 June 2016 Pages: 1053 - 1057
Comment on ‘What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain: Expert Opinion’ Raffaele GiustiLucilla VernaGiampiero Porzio Letter to the Editor 16 June 2016 Pages: 1059 - 1061
Reply—Letter to the Editor: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion Working Group Nientemale DEIR. VellucciP. Romualdi Letter to the Editor Open access 20 June 2016 Pages: 1063 - 1065
